Close
Close
Treatment Database
antisense oligonucleotide targeting exon 13 of the USH2A gene
Trade Name not avaiable
Orphan Indication Retinitis pigmentosa
USA Market Approval
USA Designation Date 27-07-2017
Sponsor ProQR Therapeutics IV B.V.
Zernikedreef 9, 2333 CK Leiden
Leiden
More about Retinitis pigmentosa
Free Newsletter
Related Videos
by Robert Derham
325 views